A Study to Evaluate Effect of Verapamil and Food of Sevasemten in Healthy Volunteers

Clinical trial NCT06916897 · COMPLETED

Trial details

NCT number: NCT06916897
Sponsor: Edgewise Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Subjects

Start date: 2025-01-08
Primary completion: 2025-02-22
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.